Elixxer Ltd (ELXR) - Total Liabilities

Latest as of September 2025: CA$17.22 Million CAD ≈ $12.46 Million USD

Based on the latest financial reports, Elixxer Ltd (ELXR) has total liabilities worth CA$17.22 Million CAD (≈ $12.46 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore ELXR net assets growth trend to track the company's year-over-year net asset growth rate.

Elixxer Ltd - Total Liabilities Trend (2017–2024)

This chart illustrates how Elixxer Ltd's total liabilities have evolved over time, based on quarterly financial data. See cash generation quality of Elixxer Ltd to measure how efficiently the company converts operating cash flow to free cash.

Elixxer Ltd Competitors by Total Liabilities

The table below lists competitors of Elixxer Ltd ranked by their total liabilities.

Company Country Total Liabilities
Itaconix plc
LSE:ITX
UK GBX3.22 Million
Multistack International Ltd
AU:MSI
Australia AU$2.90 Million
Amigo Holdings PLC
LSE:AMGO
UK GBX39.20 Million
East Star Resources PLC
LSE:EST
UK GBX1.99 Million
PT Sreeya Sewu Indonesia Tbk
JK:SIPD
Indonesia Rp1.81 Trillion
Altair Resources Inc
V:AVX
Canada CA$3.11 Million
Metgasco Ltd
AU:MEL
Australia AU$13.81 Million
Parkmead Group PLC
LSE:PMG
UK GBX5.47 Million

Liability Composition Analysis (2017–2024)

This chart breaks down Elixxer Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Elixxer Ltd (ELXR) market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 0.01 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity -1.14 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 7.93 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Elixxer Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Elixxer Ltd (2017–2024)

The table below shows the annual total liabilities of Elixxer Ltd from 2017 to 2024.

Year Total Liabilities Change
2024-12-31 CA$15.23 Million
≈ $11.02 Million
+22.72%
2023-12-31 CA$12.41 Million
≈ $8.98 Million
+13.29%
2022-12-31 CA$10.95 Million
≈ $7.92 Million
+29.54%
2021-12-31 CA$8.45 Million
≈ $6.12 Million
-47.34%
2020-12-31 CA$16.06 Million
≈ $11.61 Million
+424.04%
2018-12-31 CA$3.06 Million
≈ $2.22 Million
+161.66%
2017-12-31 CA$1.17 Million
≈ $847.04K
--

About Elixxer Ltd

V:ELXR Canada Drug Manufacturers - Specialty & Generic
Market Cap
$287.08K
CA$396.86K CAD
Market Cap Rank
#31092 Global
#1667 in Canada
Share Price
CA$0.04
Change (1 day)
+0.00%
52-Week Range
CA$0.03 - CA$1.15
All Time High
CA$99.00
About

Elixxer Ltd. operates as a cannabis investment firm in Canada, Australia, Italy, Jamaica, and Switzerland. It invests in cultivation, production, and/or sale of medical cannabis and cannabis-derived products in the pharmaceutical sector. The company was formerly known as LGC Capital Ltd. and changed its name to Elixxer Ltd. in August 2019. Elixxer Ltd. was incorporated in 2004 and is based in Mon… Read more